Thursday, 23 April 2020

The Oxford Vaccine Centre COVID-19 Phase I clinical trial explained

‘The purpose of this study is to test a new vaccine against COVID-19 in healthy volunteers. This study aims to assess whether healthy people can be protected from COVID-19 with this new vaccine called ChAdOx1 nCoV-19. It will also provide valuable information on safety aspects of the vaccine and its ability to generate good immune responses against the virus.’

Read here (The Oxford Vaccine Centre, April 23, 2020)

A WORD OF CAUTION: ‘News about trial progress - We are aware there have been and will be rumours and false reports about the progress of the trial. We urge people not to give these any credibility and not to circulate them.  We will not be offering a running commentary about the trial but all official updates will appear on this site.’

Read here (The Oxford Vaccine Centre, April 26, 2020)

Worst ever Covid variant? Omicron

John Campbell shares his findings on Omicron.  View here (Youtube, Nov 27, 2021)